Europe — EMA

Olmesartan Medoxomil Alter

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil Alter, is an Angiot‑C presented as a strength/form for oral use. It treats hypertension and is used in adult patients.

Olmesartan Medoxomil

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil Alter, is an Angiot‑C presented as a strength/form for oral use. It treats hypertension and is used in adult patients. GNH USA supplies Olmesartan Medoxomil Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxomil Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan medoxil acts on the renin‑angiotensin system for blood‑pressure management.

- Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk. - Heart failure: improves cardiac output and may reduce hospitalisation rates. - Diabetic nephropathy: slows progression of kidney damage associated with diabetes. - Post‑myocardial infarction: assists in blood‑pressure control after a heart attack. - Chronic kidney ... (the content has been truncated)

What are the side effects of Olmesartan Medoxomil?

Common

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →